HIV-1 DRUG RESISTANCE IN RESOURCE-LIMITED SETTINGS
Introduction: The global scale up of cART has now reached 17 million treated individuals, largely in LMICs. Antiretroviral therapy (ART) is pivotal for controlling HIV-1 infection through widescale treatment as prevention (TasP) and pre-exposure prophylaxis (PreP). Pre treatment drug resistance to NNRTI is associated with a 2-3 fold higher viral failure rate in both high…